EZH2 and B-cell non-Hodgkin lymphoma: This Primer discusses a recent study using simultaneous measurements of histone modifications in single cells to reveal that EZH2 gain-of-function mutations profoundly reprogram chromatin states in B-cell lymphoma, while also increasing their cell-cell heterogeneity.